I would greatly value your perspective on: The evidence regarding GLP-1 use and safety in people with MS Whether the metabolic benefits alone justify considering them in someone with my profile
In clinical settings, researchers have observed that slowing this transit can reduce the frequency of bowel movements
But if the same researcher draws 0.2ml from a 2.5mg/ml solution, they've delivered 500mcg, a 2.5 overdose that skews all subsequent data
En personas con diabetes tipo 2, el efecto incretina global est significativamente disminuido, aproximadamente un 50-70%
Side Effects: Nausea, Constipation, and How Theyre Managed The most common early side effects include nausea, constipation, and mild fatigue
Therapeutics and Clinical Risk Management, 4 (6), 1315-1330